The Transforming Growth Factor- Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy
Gerhardinger, C., Dagher, Z., Sebastiani, P., Park, Y. S., Lorenzi, M.Volume:
58
Language:
english
Journal:
Diabetes
DOI:
10.2337/db08-1008
Date:
July, 2009
File:
PDF, 245 KB
english, 2009